Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 6-MTH group results

Oct 30 (Reuters)-  
             Taisho Pharmaceutical Holdings Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   6 months ended      6 months ended       Year to  
                  Sep 30, 2017        Sep 30, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              138.63              141.01           279.00     
                   (-1.7 pct)          (-3.4 pct)       (-0.3 pct)   
  Operating           15.18               16.66            28.50     
                   (-8.9 pct)          (+19.6 pct)      (-10.8 pct)  
  Recurring           17.85               19.13            34.50     
                   (-6.7 pct)          (+8.2 pct)       (-9.3 pct)   
  Net                 12.02               13.50            24.00     
                   (-11.0 pct)         (+19.7 pct)      (-16.6 pct)  
  EPS              150.38 yen          168.93 yen       300.38 yen   
  EPS Diluted      150.26 yen          168.82 yen                    
  Ann Div                              110.00 yen       110.00 yen   
  -Q2 div           50.00 yen           50.00 yen                    
  -Q4 div                               60.00 yen        60.00 yen   
   
  NOTE - Taisho Pharmaceutical Holdings Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Taisho Pharmaceutical Holdings Co

See all news